marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 11-07-2024
Revance Therapeutics Balance Sheet 2011-2024 | RVNC
Annual Balance Sheet Revance Therapeutics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
295 M | 275 M | 170 M | -152 M | -142 M | -73.3 M | -281 M | -58.2 M | -193 M | -167 M | 21.6 M | 102 M | 39.4 M |
Long Term Debt |
427 M | 379 M | 281 M | 181 M | - | - | - | - | - | - | 2.63 M | 11 M | 63.5 M |
Long Term Debt Current |
5.7 M | 4.24 M | 4.75 M | 4.44 M | 3.47 M | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | 73.8 M | 48.8 M | 5.95 M | 7.64 M | 10.5 M | 5.86 M | 133 M | 112 M | 187 M |
Total Current Liabilities |
89.2 M | 75.7 M | 67.3 M | 61 M | 41 M | 32 M | 20.9 M | 19.6 M | 12 M | 10.2 M | - | - | - |
Total Liabilities |
630 M | 569 M | 463 M | 346 M | 115 M | 80.7 M | 26.9 M | 27.3 M | 22.6 M | 16.1 M | 180 M | 230 M | 195 M |
Deferred Revenue |
10.7 M | 6.87 M | 9.36 M | 7.85 M | 7.91 M | 8.59 M | - | - | - | - | 83 K | - | 500 K |
Retained Earnings |
-2.08 B | -1.75 B | -1.4 B | -1.13 B | -844 M | -685 M | -542 M | -422 M | -332 M | -259 M | -196 M | -218 M | -160 M |
Total Assets |
478 M | 582 M | 531 M | 720 M | 340 M | 226 M | 296 M | 204 M | 276 M | 192 M | 22.6 M | 13.4 M | 39.9 M |
Cash and Cash Equivalents |
137 M | 109 M | 116 M | 337 M | 171 M | 73.3 M | 283 M | 63.5 M | 202 M | 171 M | 3.91 M | 4.08 M | - |
Book Value |
-152 M | 12.6 M | 68.5 M | 374 M | 225 M | 146 M | 269 M | 177 M | 253 M | 176 M | -158 M | -217 M | -155 M |
Total Shareholders Equity |
-152 M | 12.6 M | 68.5 M | 374 M | 225 M | 146 M | 269 M | 177 M | 253 M | 176 M | -158 M | -217 M | - |
All numbers in USD currency
Quarterly Balance Sheet Revance Therapeutics
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
421 M | 423 M | 425 M | 427 M | 427 M | 380 M | 380 M | 379 M | 379 M | 378 M | 378 M | 281 M | 40.5 M | 41.3 M | 26.2 M | 27.1 M | 27.1 M | 27.1 M | 27.1 M | 25.9 M | 25.9 M | 25.9 M | 25.9 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Liabilities |
625 M | 625 M | 607 M | 630 M | 639 M | 571 M | 574 M | 569 M | 566 M | 565 M | 614 M | 463 M | 462 M | 455 M | 432 M | 346 M | 346 M | 346 M | 346 M | 115 M | 115 M | 115 M | 115 M | 80.7 M | 80.7 M | 80.7 M | 80.7 M | 26.9 M | 26.9 M | 26.9 M | 26.9 M | 27.3 M | 27.3 M | 27.3 M | 27.3 M | 22.6 M | 22.6 M | 22.6 M | 22.6 M | 16.1 M | 16.1 M | 16.1 M | 16.1 M | 56.2 M | 56.2 M | 56.2 M | 56.2 M | - | - | - | - | - | - | - | - |
Deferred Revenue |
6.33 M | 9.61 M | 9.78 M | 10.7 M | 5.37 M | 5.43 M | 6.04 M | 6.87 M | 12.5 M | 10.7 M | 8.98 M | 9.36 M | 10.9 M | 9.86 M | 9.05 M | 7.85 M | 7.85 M | 7.85 M | 7.85 M | 7.91 M | 7.91 M | 7.91 M | 7.91 M | 8.59 M | 8.59 M | 9.32 M | 5.53 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 83 K | 83 K | 83 K | 83 K | - | - | - | - | - | - | - | - |
Retained Earnings |
-2.21 B | -2.17 B | -2.13 B | -2.08 B | -2.02 B | -1.88 B | -1.81 B | -1.75 B | -1.61 B | -1.52 B | -1.46 B | -1.4 B | -1.33 B | -1.26 B | -1.19 B | -1.13 B | -1.13 B | -1.13 B | -1.13 B | -844 M | -844 M | -844 M | -844 M | -685 M | -685 M | -685 M | -685 M | -542 M | -542 M | -542 M | -542 M | -422 M | -422 M | -422 M | -422 M | -332 M | -332 M | -332 M | -332 M | -259 M | -259 M | -259 M | -259 M | -196 M | -196 M | -196 M | -196 M | - | - | - | - | - | - | - | - |
Total Assets |
462 M | 495 M | 508 M | 478 M | 532 M | 598 M | 548 M | 582 M | 712 M | 562 M | 640 M | 531 M | 582 M | 641 M | 676 M | 720 M | 720 M | 720 M | 720 M | 340 M | 340 M | 340 M | 340 M | 226 M | 226 M | 226 M | 226 M | 296 M | 296 M | 296 M | 296 M | 204 M | 204 M | 204 M | 204 M | 276 M | 276 M | 276 M | 276 M | 192 M | 192 M | 192 M | 192 M | 22.6 M | 22.6 M | 22.6 M | 22.6 M | - | - | - | - | - | - | - | - |
Cash and Cash Equivalents |
58.6 M | 81.5 M | 133 M | 137 M | 187 M | 149 M | 144 M | 109 M | 110 M | 75.3 M | 204 M | 111 M | 132 M | 171 M | 249 M | 337 M | 334 M | 334 M | 334 M | 171 M | 171 M | 171 M | 171 M | 73.3 M | 73.3 M | 73.3 M | 73.3 M | 283 M | 283 M | 283 M | 283 M | 63.5 M | 63.5 M | 63.5 M | 63.5 M | 202 M | 202 M | 202 M | 202 M | 171 M | 171 M | 171 M | 171 M | 3.91 M | 3.91 M | 3.91 M | 3.91 M | 4.08 M | - | - | - | 29.6 M | - | - | - |
Book Value |
-163 M | -130 M | -98.7 M | -152 M | -106 M | 26.8 M | -26.7 M | 12.6 M | 146 M | -2.63 M | 25.5 M | 68.5 M | 120 M | 186 M | 244 M | 374 M | 374 M | 374 M | 374 M | 225 M | 225 M | 225 M | 225 M | 146 M | 146 M | 146 M | 146 M | 269 M | 269 M | 269 M | 269 M | 177 M | 177 M | 177 M | 177 M | 253 M | 253 M | 253 M | 253 M | 176 M | 176 M | 176 M | 176 M | -33.6 M | -33.6 M | -33.6 M | -33.6 M | - | - | - | - | - | - | - | - |
Total Shareholders Equity |
-163 M | -130 M | -98.7 M | -152 M | -106 M | 26.8 M | -26.7 M | 12.6 M | 146 M | -2.63 M | 25.5 M | 68.5 M | 120 M | 186 M | 244 M | 374 M | 374 M | 374 M | 374 M | 225 M | 225 M | 225 M | 225 M | 146 M | 146 M | 146 M | 146 M | 269 M | 269 M | 269 M | 269 M | 177 M | 177 M | 177 M | 177 M | 253 M | 253 M | 253 M | 253 M | 176 M | 176 M | 176 M | 176 M | -158 M | -158 M | -158 M | -158 M | -217 M | - | - | - | -155 M | - | - | - |
All numbers in USD currency